The extended ocular hypotensive effect of positive liposomal cholesterol bound timolol maleate in glaucomatous rabbits

Biopharmaceutics and Drug Disposition

Volumn 32, Issue 9, 2011, Pages 507-517

  Shafaa, Medhat W ^a,b   Sabra, Neveen M ^c   Fouad, Rehab A ^a  

^a Helwan University   (Egypt)

^b JAZAN UNIVERSITY   (Saudi Arabia)

^c RESEARCH INSTITUTE OF OPHTHALMOLOGY   (Egypt)

Author keywords

DSC; glaucomatous rabbits; intraocular pressure; liposomes; timolol maleate

Indexed keywords

CHOLESTEROL; DIPALMITOYLPHOSPHATIDYLCHOLINE; DRUG CARRIER; LIPOSOME; TIMOLOL MALEATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BIOAVAILABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG FORMULATION; DRUG RELEASE; ENCAPSULATION; GLAUCOMA; INTRAOCULAR HYPERTENSION; LIPID BILAYER; LIPID VESICLE; MALE; NONHUMAN; RABBIT;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ANTIHYPERTENSIVE AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; CHOLESTEROL; DELAYED-ACTION PREPARATIONS; GLAUCOMA; INTRAOCULAR PRESSURE; LIPOSOMES; MALE; PHENOL; RABBITS; SCLEROSING SOLUTIONS; SPECTROPHOTOMETRY, ULTRAVIOLET; TIMOLOL;

EID: 82155168217     PISSN: 01422782     EISSN: 1099081X     Source Type: Journal    
DOI: 10.1002/bdd.778     Document Type: Article

References (36)

1. Le Bourlais CL, Acar L, Zia H, Sado PA, Needham T, Leverge R,. Ophthalmic drug delivery systems-recent advances. Prog Retin Eye Res 1998; 17: 35-58.
2. Velpandian T, Gupta SK, Gupta YK, Biswas NR, Agarwal HC,. Ocular drug targeting by liposomes and their corneal interactions. J Microencapsul 1999; 16: 243-250. (Pubitemid 29099605)
3. Kaur IP, Kanwar M,. Ocular preparations: the formulation approach. Drug Dev Ind Pharm 2002; 28: 473-493. (Pubitemid 34680549)
4. Kaur IP, Garg A, Singla AK, et al,. Vesicular systems in ocular delivery: an overview. Int J Pharm 2004; 269: 1-14. (Pubitemid 38035207)
5. Hui HW, Robinson JR,. Ocular drug delivery of progesterone using a bioadhesive polymer. Int J Pharm 1985; 26: 203-213. (Pubitemid 16228619)
6. Monem AS, Ali FM, Ismail MW,. Prolonged effect of liposomes encapsulating pilocarpine HCl in normal and glaucomatous rabbits. Int J Pharm 2000; 198: 29-38. (Pubitemid 30155547)
7. Ebrahim S, Peyman GA, Lee PJ,. Application of liposomes in ophthalmology. Surv Ophthalmol 2005; 50: 167-182.
8. Smolin G, Okumoto M, Feiler S, Condon D,. Idoxuridine liposome therapy for herpes simplex keratitis. Am J Ophthalmol 1981; 91: 220-225. (Pubitemid 11184484)
9. 125I-labelled idoxuridine liposomes. Acta Ophthalmol 1986; 64: 298-301. (Pubitemid 16068376)
10. Meisner D, Pringle J, Mezei M,. Liposomal ophthalmic drug delivery. III. Pharmacodynamic and biodisposition studies of atropine. Int J Pharm 1989; 55: 105-113. (Pubitemid 19253779)
11. Shafaa MW, El Shazly LH, El Shazly AH, El Gohary AA, El Hossary GG,. Efficacy of topically applied liposome-bound tetracycline in the treatment of dry eye model. Vet Ophthalmol 2011; 14: 18-25.
12. Nelson WL, Fraunfelder FT, Sills JM, Arrowsmith JB, Kuritsky JN,. Adverse respiratory cardiac events attributed to timolol ophthalmic solution. Am J Ophthalmol 1986; 102: 606-611. (Pubitemid 17175963)
13. Bangham AD, Hill MW, Miller NGA,. Preparation and use of liposomes as models of biological membranes. In Methods in Membrane Biology, Vol. 1., Karn ED, (ed). Plenum: New York, 1974; 1-68.
14. Maurice H, Luntz FRCS,. Experimental glaucoma in the rabbit. Am J Ophthalmol 1966; 61: 665-680.
15. Winum J, Casini A, Mincione F, et al,. Carbonic anhydrase inhibitors: N-(p-sulfamoyl phenyl)-α- d -glycopyranosylamines as topically acting antiglaucoma agents in hypertensive rabbits. Bioorg Med Chem Lett 2004; 14: 225-229. (Pubitemid 38010224)
16. Singh K, Mezei M,. Liposomal ophthalmic drug delivery system II: dihydrostreptomycin sulphate. Int J Pharm 1984; 19: 263-269. (Pubitemid 14120842)
17. Shields MB,. Textbook of Glaucoma (2nd edn. edn). USA: Wavery, 1987; 45-70.
18. du Plessis J, Ramachandran C, Weiner N, Muller DG,. The influence of lipid composition and lamellarity of liposomes on the physical stability of liposomes upon storage. Int J Pharm 1996; 127: 273-278. (Pubitemid 26091011)
19. Perugini P, Pavanetto F,. Liposomes containing boronophenylalanine for boron neutron capture therapy. J Microencapsul 1998; 15: 473-483. (Pubitemid 28288736)
20. Guo LSS, Sarris AM, Levy MD,. A safe bioadhesive liposomal formulation for ophthalmic applications. Invest Ophthalmol Vis Sci (Suppl) 1989; 29: 439.
21. Guo LSS, Radhakrishnan R, Redman CT,. Adhesion of positively-charged liposomes to mucosal tissues. J Liposome Res 1990; 3: 319-337.
22. Guo LSS, Redmann CT,. Radhakrishnan R. Bioadhesive liposomes in ophthalmic drug delivery. Invest Ophthalmol Vis Sci (Suppl) 1987; 28: 72.
23. Nagarsenker MS, Londhe VY,. Preparation and evaluation of a liposomal formulation of sodium cromoglicate. Int J Pharm 2003; 251: 49-56. (Pubitemid 36071459)
24. Peschka R, Dennehy C, Szoka FCJ,. A simple in vitro model to study the release kinetics of liposome encapsulated material. J Control Release 1998; 56: 41-51. (Pubitemid 28511125)
25. Fitzgerald P, Hadgraft J, Kreuter J, Wilson CG,. A gamma scintigraphic evaluation of microparticulate ophthalmic delivery systems: liposomes and nanoparticles. Int J Pharm 1987; 40: 81-84.
26. Fitzgerald P,. An assessment of the precorneal residence of ophthalmic drug delivery systems. Ph.D. Thesis. University of Nottingham, Nottingham, England, 1985.
27. Hathout RM, Mansour S, Mortada ND, Guinedi AS,. Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies. AAPS Pharm Sci Tech 2007; 8: E1-E12.
28. Shuqin X, Shiying X,. Ferrous sulfate liposomes: preparation, stability and application in fluid milk. Food Res Int 2005; 38: 289-296.
29. Fresta M, Anna P, Claudio B, Claudio G, Giovanni P,. Characterization and in-vivo ocular absorption of liposome-encapsulated acyclovir. J Pharm Pharmacol 1999; 51: 565-576. (Pubitemid 29319782)
30. Puglisi G, Fresta M, Ventura CA,. Interaction of natural and modified α-cyclodextrins with a biological membrane model of dipalmitoylphosphatidylcholine. J Colloid Interface Sci 1996; 180: 542-547. (Pubitemid 26233934)
31. Koynova R, Caffrey M,. Phases and phase transitions of the phosphatidylcholines. Biochim Biophys Acta 1998; 1376: 91-145. (Pubitemid 28321526)
32. Sharma HK, Sarangi B, Pradhan SP,. Preparation and in-vitro evaluation of mucoadhesive microbeads containing timolol maleate using mucoadhesive substances of Dillenia indica L. Arch Pharm Sci Res 2009; 1: 181-188.
33. Nagarsenker MS, Joshi AA,. Preparation, characterization and evaluation of liposomal dispersions of lidocaine. Drug Dev Ind Pharm 1997; 23: 1159-1165. (Pubitemid 28030016)
34. Nagle JF,. Theory of the main lipid bilayer phase transition. Ann Rev Phys Chem 1980; 31: 157-195.
35. Ladbrooke BD, Williams RM, Chapman D,. Studies on lecithin-cholesterol- water interactions by differential scanning calorimetry and x-ray diffraction. Biochim Biophys Acta Biomembranes 1968; 150: 333-340.
36. Mabrey S, Mateo PL, Sturtevant JM,. High-sensitivity scanning calorimetric study of mixtures of cholesterol with dimyristoyl- and dipalmitoylphosphatidylcholines. Biochemistry 1978; 17: 2464-2468. (Pubitemid 8365774)